vs
ARVINAS, INC.（ARVN）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是ARVINAS, INC.的1.4倍（$57.1M vs $41.9M），REGIS CORP净利率更高（0.8% vs -83.8%，领先84.6%），REGIS CORP同比增速更快（22.3% vs -59.1%），REGIS CORP自由现金流更多（$891.0K vs $-59.2M），过去两年ARVINAS, INC.的营收复合增速更高（10.0% vs 7.8%）
Arvinas是一家临床阶段生物技术企业，专注开发PROTAC靶向蛋白降解类疗法，用于治疗癌症及罕见病，核心管线覆盖多个存在未满足医疗需求的适应症，主要面向美国及全球生物制药市场运营。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
ARVN vs RGS — 直观对比
营收规模更大
RGS
是对方的1.4倍
$41.9M
营收增速更快
RGS
高出81.3%
-59.1%
净利率更高
RGS
高出84.6%
-83.8%
自由现金流更多
RGS
多$60.1M
$-59.2M
两年增速更快
ARVN
近两年复合增速
7.8%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $41.9M | $57.1M |
| 净利润 | $-35.1M | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | -104.5% | 10.8% |
| 净利率 | -83.8% | 0.8% |
| 营收同比 | -59.1% | 22.3% |
| 净利润同比 | 28.7% | -94.0% |
| 每股收益（稀释后） | $-0.48 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARVNRGS
| Q4 25 | — | $57.1M | ||
| Q3 25 | $41.9M | $59.0M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | $188.8M | $57.0M | ||
| Q4 24 | $59.2M | $46.7M | ||
| Q3 24 | $102.4M | $46.1M | ||
| Q2 24 | $76.5M | $49.4M | ||
| Q1 24 | $25.3M | $49.2M |
净利润ARVNRGS
| Q4 25 | — | $456.0K | ||
| Q3 25 | $-35.1M | $1.4M | ||
| Q2 25 | — | $116.5M | ||
| Q1 25 | $82.9M | $250.0K | ||
| Q4 24 | $-45.1M | $7.6M | ||
| Q3 24 | $-49.2M | $-853.0K | ||
| Q2 24 | $-35.2M | $91.2M | ||
| Q1 24 | $-69.4M | $-2.3M |
营业利润率ARVNRGS
| Q4 25 | — | 10.8% | ||
| Q3 25 | -104.5% | 10.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | 37.8% | 8.8% | ||
| Q4 24 | -98.1% | 11.8% | ||
| Q3 24 | -58.9% | 4.6% | ||
| Q2 24 | -63.4% | — | ||
| Q1 24 | -329.2% | 8.3% |
净利率ARVNRGS
| Q4 25 | — | 0.8% | ||
| Q3 25 | -83.8% | 2.3% | ||
| Q2 25 | — | 192.9% | ||
| Q1 25 | 43.9% | 0.4% | ||
| Q4 24 | -76.2% | 16.4% | ||
| Q3 24 | -48.0% | -1.9% | ||
| Q2 24 | -46.0% | 184.7% | ||
| Q1 24 | -274.3% | -4.7% |
每股收益（稀释后）ARVNRGS
| Q4 25 | — | $0.16 | ||
| Q3 25 | $-0.48 | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | $1.14 | $0.08 | ||
| Q4 24 | $-0.63 | $2.71 | ||
| Q3 24 | $-0.68 | $-0.36 | ||
| Q2 24 | $-0.49 | $38.40 | ||
| Q1 24 | $-0.97 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $787.6M | $18.4M |
| 总债务越低越好 | $600.0K | $113.3M |
| 股东权益账面价值 | $564.4M | $188.7M |
| 总资产 | $844.3M | $588.3M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资ARVNRGS
| Q4 25 | — | $18.4M | ||
| Q3 25 | $787.6M | $16.6M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | $954.3M | $13.3M | ||
| Q4 24 | $1.0B | $10.2M | ||
| Q3 24 | $1.1B | $6.3M | ||
| Q2 24 | $1.2B | $10.1M | ||
| Q1 24 | $1.2B | $5.9M |
总债务ARVNRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | $600.0K | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | $700.0K | $112.0M | ||
| Q4 24 | $800.0K | $111.5M | ||
| Q3 24 | $800.0K | $95.2M | ||
| Q2 24 | $900.0K | $99.5M | ||
| Q1 24 | $900.0K | $179.7M |
股东权益ARVNRGS
| Q4 25 | — | $188.7M | ||
| Q3 25 | $564.4M | $187.6M | ||
| Q2 25 | — | $185.6M | ||
| Q1 25 | $660.1M | $68.6M | ||
| Q4 24 | $561.7M | $66.7M | ||
| Q3 24 | $586.0M | $56.4M | ||
| Q2 24 | $600.2M | $56.8M | ||
| Q1 24 | $609.7M | $-35.8M |
总资产ARVNRGS
| Q4 25 | — | $588.3M | ||
| Q3 25 | $844.3M | $592.1M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | $1.0B | $511.2M | ||
| Q4 24 | $1.1B | $530.1M | ||
| Q3 24 | $1.2B | $508.9M | ||
| Q2 24 | $1.3B | $530.5M | ||
| Q1 24 | $1.2B | $543.7M |
负债/权益比ARVNRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | 0.00× | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | 0.00× | 1.63× | ||
| Q4 24 | 0.00× | 1.67× | ||
| Q3 24 | 0.00× | 1.69× | ||
| Q2 24 | 0.00× | 1.75× | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.1M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-59.2M | $891.0K |
| 自由现金流率自由现金流/营收 | -141.3% | 1.6% |
| 资本支出强度资本支出/营收 | 0.2% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $-361.6M | $14.9M |
8季度趋势，按日历期对齐
经营现金流ARVNRGS
| Q4 25 | — | $1.7M | ||
| Q3 25 | $-59.1M | $2.3M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | $-88.9M | $6.2M | ||
| Q4 24 | $-84.1M | $2.1M | ||
| Q3 24 | $-128.0M | $-1.3M | ||
| Q2 24 | $50.3M | $5.1M | ||
| Q1 24 | $-97.5M | $-277.0K |
自由现金流ARVNRGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | $-59.2M | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | $-89.3M | $5.9M | ||
| Q4 24 | $-84.4M | $1.7M | ||
| Q3 24 | $-128.7M | $-1.4M | ||
| Q2 24 | $49.6M | $5.1M | ||
| Q1 24 | $-97.6M | $-326.0K |
自由现金流率ARVNRGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | -141.3% | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | -47.3% | 10.3% | ||
| Q4 24 | -142.6% | 3.6% | ||
| Q3 24 | -125.7% | -3.0% | ||
| Q2 24 | 64.8% | 10.3% | ||
| Q1 24 | -385.8% | -0.7% |
资本支出强度ARVNRGS
| Q4 25 | — | 1.4% | ||
| Q3 25 | 0.2% | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | 0.2% | 0.6% | ||
| Q4 24 | 0.5% | 0.9% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 0.4% | 0.1% |
现金转化率ARVNRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | -1.07× | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARVN
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
